CMS Proposes Electronic Prior Authorization for Drugs

Why It Matters

Standardizing drug prior authorization through real‑time APIs reduces administrative burden, speeds patient access to therapy, and enhances transparency for payers and providers.

Key Takeaways

• CMS proposes FHIR‑based electronic prior authorization for all drugs by Oct 2027
• Providers must integrate APIs into EHRs, replacing fax and portal submissions
• Medicaid and CHIP plans face 24‑hour decision windows for drug PA requests
• Plans will publicly report PA metrics, including denial reasons and appeal outcomes

Pulse Analysis

The CMS proposal marks a decisive step toward full interoperability in the U.S. healthcare payment system. By requiring Fast Healthcare Interoperability Resources (FHIR) APIs and National Council for Prescription Drug Programs (NCPDP) standards, the agency aims to replace legacy fax and portal workflows with seamless, real‑time electronic prior authorization (e‑PA) for drugs. This shift aligns with earlier interoperability mandates for medical services and reflects a broader federal push to modernize health IT infrastructure, promising faster, more accurate data exchange between providers, payers, and patients.

Compliance timelines are aggressive: Medicare Advantage, Medicaid managed care organizations, and ACA marketplace insurers must have functional APIs by January 1, 2027, with full e‑PA capability for prescriptions slated for October 2027. The rule also tightens decision windows, imposing 24‑hour turnaround for urgent drug requests under Medicaid and CHIP, and 72‑hour standards for standard requests in marketplace plans. Providers will need to embed FHIR‑based PA capabilities into their electronic health records, enabling instant alerts when a medication requires authorization and allowing direct submission from the point of care. Transparency requirements expand, obligating plans to publish detailed PA metrics, including denial reasons and appeal outcomes, fostering greater accountability.

Industry stakeholders are already moving in parallel. Health‑plan groups such as AHIP and UnitedHealthcare have pledged to cut prior‑authorization volume and accelerate payments, especially for rural providers. However, the rollout is not without challenges; the CMS‑led WISeR model illustrates how AI‑driven PA can inadvertently lengthen wait times for certain services. As the 2027 deadline approaches, the balance between technological efficiency and patient‑centric care will be a focal point for regulators, payers, and clinicians alike, shaping the next era of value‑based healthcare delivery.